The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: An indirect comparison in a systematic review

John A. Ford; Andrew Elders; Deepson Shyangdan; Pamela Royle; Norman Waugh

doi:10.1136/bmj.e5182

The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: An indirect comparison in a systematic review

John A. Ford, Andrew Elders, Deepson Shyangdan, Pamela Royle, Norman Waugh

Research output: Contribution to journal › Article › peer-review

61 Citations (Scopus)

Abstract

To indirectly compare the effectiveness of ranibizumab and bevacizumab in the treatment of diabetic macular oedema.

Original language	English
Article number	e5182
Journal	BMJ-British Medical Journal
Volume	345
DOIs	https://doi.org/10.1136/bmj.e5182
Publication status	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Angiogenesis Inhibitors
Antibodies, Monoclonal, Humanized
Bayes Theorem
Diabetic Retinopathy
Humans
Macular Edema
Markov Chains
Monte Carlo Method
Treatment Outcome
Visual Acuity

Access to Document

10.1136/bmj.e5182

Cite this

@article{aa5fd130593a4d118c17c405649d66b0,

title = "The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: An indirect comparison in a systematic review",

abstract = "To indirectly compare the effectiveness of ranibizumab and bevacizumab in the treatment of diabetic macular oedema.",

keywords = "Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized, Bayes Theorem, Diabetic Retinopathy, Humans, Macular Edema, Markov Chains, Monte Carlo Method, Treatment Outcome, Visual Acuity",

author = "Ford, {John A.} and Andrew Elders and Deepson Shyangdan and Pamela Royle and Norman Waugh",

year = "2012",

doi = "10.1136/bmj.e5182",

language = "English",

volume = "345",

journal = "BMJ-British Medical Journal",

issn = "1759-2151",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: An indirect comparison in a systematic review

AU - Ford, John A.

AU - Elders, Andrew

AU - Shyangdan, Deepson

AU - Royle, Pamela

AU - Waugh, Norman

PY - 2012

Y1 - 2012

N2 - To indirectly compare the effectiveness of ranibizumab and bevacizumab in the treatment of diabetic macular oedema.

AB - To indirectly compare the effectiveness of ranibizumab and bevacizumab in the treatment of diabetic macular oedema.

KW - Angiogenesis Inhibitors

KW - Antibodies, Monoclonal, Humanized

KW - Bayes Theorem

KW - Diabetic Retinopathy

KW - Humans

KW - Macular Edema

KW - Markov Chains

KW - Monte Carlo Method

KW - Treatment Outcome

KW - Visual Acuity

U2 - 10.1136/bmj.e5182

DO - 10.1136/bmj.e5182

M3 - Article

C2 - 22890029

SN - 1759-2151

VL - 345

JO - BMJ-British Medical Journal

JF - BMJ-British Medical Journal

M1 - e5182

ER -